Target intelligence / Profile preview

Kruppel-like factor 12 (KLF12) mRNA 3′ untranslated region (3′UTR) (KLF12 mRNA 3′UTR)

Target
KLF12 mRNA 3′UTR
Molecular classification
RNA regulatory element, Untranslated region
01

Overview

The Kruppel-like factor 12 (KLF12) mRNA 3′ untranslated region (3′UTR) is a regulatory sequence located immediately downstream of the KLF12 coding region, playing a pivotal role in the post-transcriptional control of KLF12 expression (UniProt Q9Y4X4). KLF12 itself is a zinc-finger transcription factor that typically acts as a repressor, influencing biological processes such as the cell cycle, lung development, and various oncogenic pathways (PubMed: 29328357). The 3′UTR serves as a primary docking site for microRNAs (miRNAs), including miR-141, miR-20b, and miR-137, which bind to specific seed sequences to induce mRNA degradation or inhibit translation (PubMed: 32154012, PubMed: 30603484). In the context of oncology, the interaction between these miRNAs and the KLF12 3′UTR is frequently disrupted, leading to the overexpression of KLF12 and subsequent promotion of tumor cell proliferation and metastasis in gastric, colorectal, and lung cancers (PubMed: 29328357). As a result, this region is considered a significant target for RNA-based therapeutics, such as miRNA mimics or antisense oligonucleotides, aimed at restoring regulatory control over KLF12 (PubMed: 32154012). Therapeutic development focusing on this target faces challenges common to RNA-targeted drugs, including the need for efficient delivery systems and the mitigation of off-target effects (PubMed: 30603484). Understanding the structural and sequence-specific interactions within this 3′UTR is essential for developing precise interventions that can restore normal cellular homeostasis in KLF12-associated diseases.

Other names
AP-2rep mRNA 3′UTRB1-binding protein mRNA 3′UTRKruppel-like factor 12 3′-UTR
02

Mechanism of action

MicroRNA-mediated gene silencing through sequence-specific binding to the 3′UTR, leading to mRNA degradation or translational repression of the KLF12 transcript (PubMed: 29328357, PubMed: 32154012).

03

Biological functions

Regulation of gene expressionmRNA stabilityTranslational inhibitionCell proliferation regulation
04

Disease associations

Gastric cancerColorectal cancerLung cancerEndometrial cancer
05

Safety considerations

Off-target effects of miRNA-based therapiesDelivery vehicle toxicityPotential for unintended gene silencing in non-target tissues
06

Interacting drugs

miR-141-3p mimics

3 more in the full profile.

07

Biomarkers

KLF12 mRNA levelsmiR-141 expressionmiR-20b expression

Beyond the preview

Go deeper on Kruppel-like factor 12 (KLF12) mRNA 3′ untranslated region (3′UTR) (KLF12 mRNA 3′UTR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kruppel-like factor 12 (KLF12) mRNA 3′ untranslated region (3′UTR) (KLF12 mRNA 3′UTR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call